HomepageNHIQ • OTCMKTS
add
NantHealth
Vorige slotkoers
$ 0,00010
Dag-range
$ 0,00010 - $ 0,00010
Beurswaarde
2,75K USD
Gem. volume
187,00
Koers/winst
-
Dividendrendement
-
Primaire beurs
OTCMKTS
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | sep 2023info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 12,47 mln. | — |
Bedrijfskosten | 12,17 mln. | — |
Netto inkomsten | -14,99 mln. | — |
Netto winstmarge | -120,20 | — |
Winst per aandeel | — | — |
EBITDA | -175,00K | — |
Effectief belastingtarief | -0,36% | — |
Balans
Totale activa
Totale passiva
| (USD) | sep 2023info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 5,82 mln. | — |
Totale activa | 146,48 mln. | — |
Totale passiva | 396,66 mln. | — |
Totaal aandelenvermogen | -250,18 mln. | — |
Uitstaande aandelen | 27,47 mln. | — |
Koers-boekwaardeverhouding | -0,00 | — |
Rendement op activa | -8,24% | — |
Rendement op kapitaal | -41,68% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | sep 2023info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -14,99 mln. | — |
Operationele kasstroom | -7,65 mln. | — |
Kasstroom uit beleggingen | 11,00K | — |
Kasstroom uit financiering | 7,50 mln. | — |
Nettomutatie in liquide middelen | -298,00K | — |
Vrije kasstroom | -3,94 mln. | — |
Over
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Opgericht
7 jul 2010
Website
Werknemers
373
